DaVita Inc. (NYSE:DVA) Shares Purchased by National Bank of Canada FI

Key Points

• National Bank of Canada FI increased its stake in DaVita Inc. by 30.8%, owning approximately 0.07% of the company valued at $8.23 million.
• Several institutional investors, including UMB Bank and Copia Wealth Management, have made significant increases in their positions in DaVita, reflecting a strong interest from the investment community.
• DaVita recently reported earnings per share of $2.95, exceeding analysts' estimates, as revenue grew 6.1% year-over-year, indicating positive financial performance.

National Bank of Canada FI lifted its position in DaVita Inc. (NYSE:DVA - Free Report) by 30.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 53,791 shares of the company's stock after purchasing an additional 12,666 shares during the quarter. National Bank of Canada FI owned about 0.07% of DaVita worth $8,230,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. United Capital Financial Advisors LLC boosted its holdings in DaVita by 2.6% in the fourth quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock valued at $361,000 after purchasing an additional 62 shares during the last quarter. Freedom Investment Management Inc. boosted its holdings in DaVita by 3.6% in the fourth quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock valued at $268,000 after purchasing an additional 62 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in DaVita by 2.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock valued at $531,000 after purchasing an additional 69 shares during the last quarter. UMB Bank n.a. boosted its stake in shares of DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its stake in shares of DaVita by 8.9% during the 1st quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock worth $148,000 after acquiring an additional 79 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on DVA shares. Truist Financial set a $148.00 price target on shares of DaVita in a research note on Friday, August 8th. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Finally, Barclays cut their price target on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th.

Insider Buying and Selling

In other news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares of the company's stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is owned by corporate insiders.

DaVita Stock Up 0.7%

DVA stock traded up $0.96 during midday trading on Friday, hitting $135.35. The company's stock had a trading volume of 721,001 shares, compared to its average volume of 925,075. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 52-week low of $126.07 and a 52-week high of $179.60. The firm has a market capitalization of $9.68 billion, a P/E ratio of 13.31, a PEG ratio of 0.97 and a beta of 1.09. The firm has a 50-day simple moving average of $139.68 and a 200-day simple moving average of $145.28.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating the consensus estimate of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The company had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. During the same quarter last year, the company posted $2.00 EPS. The firm's revenue was up 6.1% compared to the same quarter last year. As a group, equities analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.